Global Bio-Chem Subsidiary Launches Pilot Testing Platform at Xinglongshan Site
Global Bio-Chem Technology Group Co. Ltd. has announced a strategic cooperation plan involving its subsidiary to establish a pilot testing platform at the Xinglongshan production site. This move aims to support the industrialization of biobased chemicals and medical materials. Despite the suspension of operations at the Xinglongshan site, efforts are underway to introduce new business alliances or investors to resume production. The unveiling ceremony for the pilot testing platform was held successfully, marking a significant step toward transforming technological achievements into industrial outcomes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on May 23, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。